Annexon

$24.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.15 (-0.61%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Annexon and other stocks, options, and ETFs commission-free!

About ANNX

Annexon, Inc. Common Stock, also called Annexon, is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. Read More It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in South San Francisco, CA. The listed name for ANNX is Annexon, Inc. Common Stock.

Employees
24
Headquarters
South San Francisco, California
Founded
2011
Market Cap
932.34M
Price-Earnings Ratio
Dividend Yield
Average Volume
123.62K
High Today
$24.85
Low Today
$23.90
Open Price
$24.44
Volume
117.19K
52 Week High
$31.84
52 Week Low
$15.33

Collections

ANNX Earnings

-$28.87
-$19.25
-$9.62
-$0.00
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 10, After Hours

You May Also Like